Perfluorohexyloctane
Semifluorinated Alkane
Also known as: F6H8, miebo, NOV03, perfluorhexyloctane
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Perfluorohexyloctane is an onp drug in the Semifluorinated Alkane class catalogued in DrugCentral. It was first approved by the FDA in 2023. Recorded indications include Dry eye disease.
- Approval status: onp (first approved 2023 by the FDA).
- Drug class: Semifluorinated Alkane.
- Indications: Dry eye disease.
- Molecular formula: C14H17F13; molecular weight 432.27 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Dry eye disease
Mechanism & targets
| Established pharmacologic class | Semifluorinated Alkane |
|---|
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2023-05-18 | FDA | — | BAUSCH AND LOMB INC |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Eye irritation | 178.0 |
| Eye pain | 97.6 |
| Ocular hyperaemia | 94.7 |
| Vision blurred | 84.3 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Perfluorohexyloctane is on its molecule page.
| Molecular formula | C14H17F13 |
|---|---|
| Molecular weight | 432.27 g/mol |
| CAS number | 133331-77-8 |
| InChIKey | WRYIIOKOQSICTB-UHFFFAOYSA-N |
| PubChem CID | 10477896 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Perfluorohexyloctane used for?
DrugCentral lists the following indications for Perfluorohexyloctane: Dry eye disease.
When was Perfluorohexyloctane first approved?
Perfluorohexyloctane was first approved by the FDA in 2023.
What drug class does Perfluorohexyloctane belong to?
Perfluorohexyloctane is in the Semifluorinated Alkane class.
What is the chemical formula of Perfluorohexyloctane?
Perfluorohexyloctane has the molecular formula C14H17F13 and a molecular weight of 432.27 g/mol.
Browse: all drugs starting with P · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 5730 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL5314588 — compound record and bioactivity
- PubChem CID 10477896 — chemical identifiers
- FDA UNII 7VYX4ELWQM — substance identity
- DailyMed: FDA labels for Perfluorohexyloctane — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.